{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T01:38:03Z","timestamp":1706146683528},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[1994,1]]},"DOI":"10.1007\/bf01517171","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T23:01:45Z","timestamp":1113865305000},"page":"61-67","source":"Crossref","is-referenced-by-count":1,"title":["Soluble factors produced by macrophages\/monocytes inhibit lymphokine-activated killer activity in rat splenocyte cultures"],"prefix":"10.1007","volume":"38","author":[{"given":"Peter J. K.","family":"Kuppen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander M. M.","family":"Eggermont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rianne B. W. M.","family":"Quak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis J. H.","family":"van de Velde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert Jan","family":"Fleuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00002371-199205000-00002","volume":"11","author":"GDM Beun","year":"1992","unstructured":"Beun GDM, Eendenburg JDH van, Corver WE, Velde CJH van de, Fleuren GJ (1992) T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. I. Significant bispecific lysis of syngeneic colon carcinoma CC531 is critically dependent on prolonged preactivation of effector T-lymphocytes by immobilized anti-T-cell receptor antibody. J Immunother 11:238","journal-title":"J Immunother"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1084\/jem.138.3.574","volume":"138","author":"JD Broome","year":"1973","unstructured":"Broome JD, Jeng MW (1973) Promotion of replication in lymphoid cells by specific thiols and disulfides in vitro. Effect on mouse lymphoma cells in comparison with splenic lymphocytes. J Exp Med 138:574","journal-title":"J Exp Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ijc.2910480513","volume":"48","author":"MJ Brunda","year":"1991","unstructured":"Brunda MJ, Sulich V, Wright RB, Palleroni AV (1991) Tumoricidal activity and cytokine secretion by tumor-infiltrating macrophages. Int J Cancer 48:704","journal-title":"Int J Cancer"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1084\/jem.136.3.604","volume":"136","author":"C Chen","year":"1972","unstructured":"Chen C, Hirsch JG (1972) The effects of mercaptoethanol and of peritoneal macrophages on the antibody-forming capacity of nonadherent mouse spleen cells in vitro. J Exp Med 136:604","journal-title":"J Exp Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/250667a0","volume":"250","author":"SA Eccles","year":"1974","unstructured":"Eccles SA, Alexander P (1974) Macrophage content of tumours in relation to metastatic spread and host immune reaction. Nature 250:667","journal-title":"Nature"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/bjc.1987.164","volume":"56","author":"AMM Eggermont","year":"1987","unstructured":"Eggermont AMM, Steller EP, Matthews W, Sugarbaker PH (1987) Alloimmune cells consume interleukin-2 and competitively inhibit the anti-tumour effects of interleukin-2. Br J Cancer 56:97","journal-title":"Br J Cancer"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF01741405","volume":"31","author":"A Eisenthal","year":"1990","unstructured":"Eisenthal A (1990) Indomethacin up-regulates the generation of lymphokine-activated kill-cell activity and antibody-dependent cellular cytotoxicity mediated by interleukin-2. Cancer Immunol Immunother 31:342","journal-title":"Cancer Immunol Immunother"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.4049\/jimmunol.136.9.3420","volume":"136","author":"A El-Hag","year":"1986","unstructured":"El-Hag A, Lipsky PE, Bennett M, Clark RA (1986) Immunomodulation by neutrophil myeloperoxidase and hydrogen peroxide: differential susceptibility of human lymphocyte functions. J Immunol 136:3420","journal-title":"J Immunol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0008-8749(90)90184-S","volume":"129","author":"H Gm\u00fcnder","year":"1990","unstructured":"Gm\u00fcnder H, Eck H-P, Benninghoff B, Roth S, Dr\u00f6ge W (1990) Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteine. Cell Immunol 129:32","journal-title":"Cell Immunol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1002\/1097-0142(19871215)60:12<3001::AID-CNCR2820601224>3.0.CO;2-8","volume":"60","author":"H-A Horst","year":"1987","unstructured":"Horst H-A, Horny H-P (1987) Characterization and frequency distribution of lymphoreticular infiltrates in axillary lymph node metastases of invasive ductal carcinoma of the breast. Cancer 60:3001","journal-title":"Cancer"},{"key":"CR11","first-page":"2834","volume":"46","author":"M Hoyer","year":"1986","unstructured":"Hoyer M, Meineke T, Lewis W, Zwilling B, Rinehart J (1986) Characterization and modulation of human lymphokine (interleukin 2) activated killer cell induction. Cancer Res 46:2834","journal-title":"Cancer Res"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00199917","volume":"29","author":"K Itoh","year":"1989","unstructured":"Itoh K, Pellis NR, Balch CM (1989) Monocyte-dependent, serumborne suppressor of induction of lymphokine-activated killer cells in lymphocytes from melanoma patients. Cancer Immunol Immunother 29:57","journal-title":"Cancer Immunol Immunother"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/eji.1830030702","volume":"3","author":"E Katz-Heber","year":"1973","unstructured":"Katz-Heber E, Peck AB, Click RE (1973) Immune responses in vitro. II. Mixed leukocyte interaction in a protein-free medium. Eur J Immunol 3:379","journal-title":"Eur J Immunol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF01742524","volume":"33","author":"PJK Kuppen","year":"1991","unstructured":"Kuppen PJK, Eggermont AMM, Marinelli A, Heer E de, Velde CJH van de, Fleuren GJ (1991) Induction of lymphokine-activated killer activity in rat splenocyte cultures: the importance of 2-mercaptoethanol and indomethacin. Cancer Immunol Immunother 33:28","journal-title":"Cancer Immunol Immunother"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ijc.2910520219","volume":"52","author":"PJK Kuppen","year":"1992","unstructured":"Kuppen PJK, Marinelli A, Camps JAJ, Pauwels EKJ, Velde CJH van de, Fleuren GJ, Eggermont AMM (1992) Biodistribution of lymphokine-activated killer (LAK) cells in Wag rats after hepatic-artery or jugular-vein infusion. Int J Cancer 52:266","journal-title":"Int J Cancer"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF01742257","volume":"36","author":"PJK Kuppen","year":"1993","unstructured":"Kuppen PJK, Eggermont AMM, Smits KM, Eendenburg JDH van, Lazeroms SPG, Velde van de CJH, Fleuren GJ (1993) The development and purification of a bispecific antibody for lymphokine-activated killer cell targeting against the rat colon carcinoma CC531. Cancer Immunol Immunother 36:403","journal-title":"Cancer Immunol Immunother"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4049\/jimmunol.117.2.388","volume":"117","author":"H Lemke","year":"1976","unstructured":"Lemke H, Opitz HG (1976) Function of 2-mercaptoethanol as a macrophage substitute in the primary immune response in vitro. J Immunol 117:388","journal-title":"J Immunol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0008-8749(89)90298-0","volume":"123","author":"KH Leung","year":"1989","unstructured":"Leung KH (1989) Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2. Cell Immunol 123:384","journal-title":"Cell Immunol"},{"key":"CR19","first-page":"68","volume":"53","author":"LS Manning","year":"1989","unstructured":"Manning LS, Bowman RV, Davis MR, Musk AW, Robinson BWS (1989) Indomethacin augments lymphokine-activated killer cell generation by patients with malignant mesothelioma. Clin Immunol 53:68","journal-title":"Clin Immunol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1084\/jem.142.6.1534","volume":"142","author":"D Metcalf","year":"1975","unstructured":"Metcalf D, Nossal GJV, Warner NL, Miller JFAP, Mandel TE, Layton JE, Gutman GA (1975) Growth of B-lymphocyte colonies in vitro. J Exp Med 142:1534","journal-title":"J Exp Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.4049\/jimmunol.146.8.2719","volume":"146","author":"CD Mills","year":"1991","unstructured":"Mills CD (1991) Molecular basis of ?suppressor? macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J Immunol 146:2719","journal-title":"J Immunol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ijc.2910410108","volume":"41","author":"A Nii","year":"1988","unstructured":"Nii A, Sone S, Utsugi T, Yanagawa H, Ogura T (1988) Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state. Int J Cancer 41:33","journal-title":"Int J Cancer"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000217694","volume":"12","author":"H Ohnishi","year":"1991","unstructured":"Ohnishi H, Lin TH, Nakajima I, Chu TM (1991) Prostaglandin E2 from macrophages of murine splenocyte cultures inhibits the generation of lymphokine-activated killer cell activity. Tumor Biol 12:99","journal-title":"Tumor Biol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1084\/jem.164.4.1193","volume":"164","author":"JR Ortaldo","year":"1986","unstructured":"Ortaldo JR, Mason A, Overton R (1986) Lymphokine-activated killer cells. Analysis of progenitors and effectors. J Exp Med 164:1193","journal-title":"J Exp Med"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0192-0561(82)90060-1","volume":"4","author":"C Patrono","year":"1982","unstructured":"Patrono C, Patrignani P (1982) Pharmacologic modulation of arachidonic acid metabolism in man. A minireview with emphasis on radioimmunological methods used to quantitate drug effects. Int J Immunopharmacol 4:127","journal-title":"Int J Immunopharmacol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/eji.1830030813","volume":"3","author":"AB Peck","year":"1973","unstructured":"Peck AB, Katz-Heber E, Click RE (1973) Immune responses in vitro. IV. A comparison of the protein-free and mouse serum-supplemented mouse mixed lymphocyte interaction assays. Eur J Immunol 3:516","journal-title":"Eur J Immunol"},{"key":"CR27","first-page":"166","volume":"67","author":"HH Ravenswaay Claasen van","year":"1992","unstructured":"Ravenswaay Claasen HH van, Kluin PM, Fleuren GJ (1992) Tumor infiltrating cells in human cancer: on the possible role of CD16-macrophages in antitumor cytotoxicity. Lab Invest 67:166","journal-title":"Lab Invest"},{"key":"CR28","first-page":"4690","volume":"49","author":"MD Roth","year":"1989","unstructured":"Roth MD, Golub SH (1989) Inhibition of lymphokine-activated killer cell function by human alveolar macrophages. Cancer Res 49:4690","journal-title":"Cancer Res"},{"key":"CR29","first-page":"137","volume":"19","author":"A Sarin","year":"1991","unstructured":"Sarin A (1991) Suppression of in vitro generation of adherent lymphokine-activated killer cells by a soluble factor released spontaneously by rat spleen cells in culture. Med Sci Res 19:137","journal-title":"Med Sci Res"},{"key":"CR30","first-page":"603","volume":"19","author":"A Sarin","year":"1991","unstructured":"Sarin A, Saxena RK (1991) Restoration of interleukin-2 induced NK cell activation by depletion of adherent cells from rat spleen cells. Med Sci Res 19:603","journal-title":"Med Sci Res"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1172\/JCI110527","volume":"69","author":"WE Seaman","year":"1982","unstructured":"Seaman WE, Gindhart TD, Blackman MA, Dalal B, Talal N, Werb Z (1982) Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes. Requirements for reactive metabolites of oxygen. J Clin Invest 69:876","journal-title":"J Clin Invest"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.4049\/jimmunol.141.12.4395","volume":"141","author":"H Shau","year":"1988","unstructured":"Shau H, Kim A (1988) Suppression of lymphokine-activated killer induction by neutrophils. J Immunol 141:4395","journal-title":"J Immunol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ijc.2910440130","volume":"44","author":"SM Singh","year":"1989","unstructured":"Singh SM, Sone S, Inamura N, Ogura T (1989) Up-regulation by granulocyte-macrophage colony-stimulating factor (GM-CSF) of induction of lymphokine (IL-2)-activated killer (LAK) cells by human blood monocytes. Int J Cancer 44:170","journal-title":"Int J Cancer"},{"key":"CR34","first-page":"89","volume":"4","author":"S Sone","year":"1991","unstructured":"Sone S, Munekata M, Nakamura A, Sugihara K, Nii A, Ogura T (1991) Characterization and kinetics of a new monokine responsible for suppression of induction of lymphokine (IL-2)-activated killer activity. Cancer J 4:89","journal-title":"Cancer J"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.139.1.29","volume":"139","author":"S Sone","year":"1987","unstructured":"Sone S, Utsugi T, Nii A, Ogura T (1987) Effects of human alveolar macrophages on the induction of lymphokine (IL 2)-activated killer cells. J Immunol 139:29","journal-title":"J Immunol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/80.6.425","volume":"80","author":"S Sone","year":"1988","unstructured":"Sone S, Utsugi T, Nii A, Ogura T (1988) Differential effects of recombinant interferons ?, ?, and ? on induction of human lymphokine (IL-2)-activated killer activity. J Natl Cancer Inst 80:425","journal-title":"J Natl Cancer Inst"},{"key":"CR37","first-page":"430","volume":"6","author":"PH Sugarbaker","year":"1987","unstructured":"Sugarbaker PH, Matthews W, Steller EP, Eggermont AMM (1987) Inhibitory effects of alloimmune T cells on the generation of cytolytic responses of lymphokine-activated killer cells. J Biol Resp Mod 6:430","journal-title":"J Biol Resp Mod"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1084\/jem.165.3.628","volume":"165","author":"H Watanabe","year":"1987","unstructured":"Watanabe H, Bannai S (1987) Induction of cystine transport activity in mouse peritoneal macrophages. J Exp Med 165:628","journal-title":"J Exp Med"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01517171\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01517171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01517171\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01517171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:43:12Z","timestamp":1706143392000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01517171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["BF01517171"],"URL":"https:\/\/doi.org\/10.1007\/bf01517171","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}